Relative Vaccine Protection, Disease Severity and Symptoms Associated with Infection with SARS-CoV-2 Omicron Subvariant Ba.2.86 and Descendent Jn.1: A Danish Nationwide Register-Based Study

Ida Rask Moustsen‐Helms(Statens Serum Institut), Christian Holm Hansen(Statens Serum Institut), Palle Valentiner‐Branth(Statens Serum Institut), Silje Vermedal Hoeg(Odense University Hospital), Henrik Ullum(Statens Serum Institut), Dorte Terp Andersen(Odense University Hospital), Ramona Trebbien(Ministry of External Affairs), Lasse Engbo Christiansen, Bolette Søborg(Statens Serum Institut), Pikka Jokelainen(Statens Serum Institut), Lene Nielsen(University of Southern Denmark), Morten Rasmussen, Peter Bager(Statens Serum Institut), Vithiagaran Gunalan(Statens Serum Institut), Lasse S Vestergaard(Statens Serum Institut), Casper Westergaard(Statens Serum Institut), Marc Bennedbæk(Statens Serum Institut), Tyra Grove Krause(Statens Serum Institut), Tine Graakjær Larsen, Frederik Trier Møller(Statens Serum Institut), Ea Sofie Marmolin, Thomas Vognbjerg Sydenham(University of Southern Denmark), Leandro Andrés Escobar-Herrera, Marianne Kragh Thomsen(Aarhus University), Sophie Gubbels(Statens Serum Institut), Esben Mørk Hartmann(Statens Serum Institut), Tina Vasehus Madsen(Slagelse Hospital), Aleksander Ring(Statens Serum Institut), Mette Pinholt(Hvidovre Hospital), David Fuglsang-Damgaard, Josefine Tange Møller(Zealand University Hospital), Nina R. Steenhard(Statens Serum Institut)
SSRN Electronic Journal
January 1, 2024
Cited by 5


Related Papers